Product Information
ADMELOG SOLOSTAR 100 UNIT/ML is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $12.1092 per ML under NDC 00024592505. Its NADAC has been published 424 times since Aug 22, 2018.
Strength
100 U/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024592505
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA209196On Market Since
12/11/2017
Pharmacological Classes
Price Statistics
The NADAC for ADMELOG SOLOSTAR 100 UNIT/ML has been published 424 times since Aug 22, 2018, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.1092 per ML |
|---|---|
| All-time high | $28.9328 (Jun 12, 2019) |
| All-time low | $12.0980 (Aug 23, 2023) |
| 52-week high | $12.1202 |
| 52-week low | $12.1052 |
| Median price | $12.1424 |
| Average price | $15.1971 |
| Largest weekly change | -44.0% (Jul 10, 2019) |
| Weeks tracked | 424 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin lispro market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADMELOG SOLOSTAR 100 UNIT/ML?
The current National Average Drug Acquisition Cost (NADAC) for ADMELOG SOLOSTAR 100 UNIT/ML, manufactured by Sanofi-Aventis U.S. LLC, is $12.1092 per ML (NDC 00024592505), effective Sep 30, 2026.
How has the price of ADMELOG SOLOSTAR 100 UNIT/ML changed over time?
Over the history we have for it, the NADAC for ADMELOG SOLOSTAR 100 UNIT/ML has declined 58.1%. It has been tracked across 424 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for ADMELOG SOLOSTAR 100 UNIT/ML?
Since Aug 22, 2018, the NADAC for ADMELOG SOLOSTAR 100 UNIT/ML has ranged from a low of $12.0980 (Aug 23, 2023) to a high of $28.9328 (Jun 12, 2019), with a median of $12.1424 per ML.
Are there cheaper alternatives to ADMELOG SOLOSTAR 100 UNIT/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ADMELOG 100 UNIT/ML VIAL, is $9.3938 per ML — about 22% below ADMELOG SOLOSTAR 100 UNIT/ML.
Who manufactures ADMELOG SOLOSTAR 100 UNIT/ML?
ADMELOG SOLOSTAR 100 UNIT/ML (NDC 00024592505) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.